# The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach

> **NCT03643913** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 52 (actual)

## Conditions studied

- Shoulder Pain
- Anesthesia

## Interventions

- **PROCEDURE:** Deep neuromuscular block
- **PROCEDURE:** Moderate neuromuscular block
- **DRUG:** Neuromuscular Blocking Agents and reversing agents

## Key facts

- **NCT ID:** NCT03643913
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643913, "The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03643913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*